Joint Formulary & PAD

Strontium ranelate - Osteoporosis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Sachets (granules)
Associated Icons :
Guidelines
NFD1
Restrictions / Comments :

PAD Profile

ChemicalSubstance :
Strontium ranelate
Indication :
Osteoporosis
Group Name :
Keywords :
Brand Names Include :
Aristo
Important Information :

Strontium ranelate granules have only been available as an unlicensed product for several years but have now been discontinued (Sep 2025).

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
3

Committee Recommendations (0)

  • No records returned.

Other Indications

Below are listed other indications that Strontium ranelate is used to treat.

  • No records returned.